Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-24 @ 9:56 PM
NCT ID:
NCT02500732
Eligibility Criteria:
Inclusion Criteria:
* 1 or more syncopal spells in the year preceding enrolment
* More than -2 points on the Calgary Syncope Symptom Score
* Age ≥18 years with informed consent
Exclusion Criteria:
* Other causes of syncope, such as ventricular tachycardia, complete heart block, orthostatic hypotension or hypersensitive carotid sinus syndrome
* Inability to give informed consent
* important valvular, coronary, myocardial or conduction abnormality or significant arrhythmia.
* hypertrophic cardiomyopathy
* a permanent pacemaker
* a seizure disorder
* hypertension defined as \>150/90 mm Hg
* pregnancy
* glaucoma
* medications with known effects on blood pressure
* Known hypersensitivity to atomoxetine and derivatives
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02500732
Study Brief:
Protocol Section:
NCT02500732